Ownership of Voyager Therapeutics is distributed among prominent institutional investment firms, specialized healthcare asset managers, and venture capital entities. Major institutional stakeholders typically include prominent financial institutions such as Foresite Capital Management, Wellington Management Group, BlackRock, and Vanguard Group, alongside corporate insiders and specialized biotechnology funds. These large shareholders monitor corporate governance, vote on clinical strategy resolutions, and provide the capital backing necessary for long-term research development.